NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
Journal of Clinical Investigation · 2023
DOI: 10.1172/jci157272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Yen-Po Tsao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lupus Nephritis, Nucleic Acids. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, Yen Tjing Ling Medical Foundation, National Yang-Ming University Far Eastern Memorial Hospital Joint Research Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
- Division of Allergy, Immunology and Rheumatology, Department of Medicine, and.
- Division of Holistic and Multidisciplinary Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan.
- Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan.
Förderung
- Ministry of Science and Technology, Taiwan
- Yen Tjing Ling Medical Foundation
- National Yang-Ming University Far Eastern Memorial Hospital Joint Research Program
- National Yang Ming Chiao Tung University School of Medicine of Development and Construction program
- Szu-Yuan Research Foundation of Internal Medicine
- Cancer Progression Research Center, National Yang-Ming University, from the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan
Zitieren
APA
Tsao, Y. P., Tseng, F. Y., Chao, C. W., Chen, M. H., Yeh, Y. C., Abdulkareem, B. O., Chen, S. Y., Chuang, W. T., Chang, P. C., Chen, I. C., Wang, P. H., Wu, C. S., Tsai, C. Y., & Chen, S. T. (2023). NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression. Journal of Clinical Investigation. https://doi.org/10.1172/jci157272
Vancouver
Tsao YP, Tseng FY, Chao CW, Chen MH, Yeh YC, Abdulkareem BO, et al. NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression. Journal of Clinical Investigation. 2023. doi:10.1172/jci157272
BibTeX
@article{Tsao2023,
author = {Tsao, Yen-Po and Tseng, Fang-Yu and Chao, Chih-Wei and Chen, Ming-Han and Yeh, Yi-Chen and Abdulkareem, Babamale Olarewaju and Chen, Se-Yi and Chuang, Wen-Ting and Chang, Pei-Ching and Chen, I-Chun and Wang, Pin-Hsuan and Wu, Chien-Sheng and Tsai, Chang-Youh and Chen, Szu-Ting},
title = {NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression},
journal = {Journal of Clinical Investigation},
year = {2023},
doi = {10.1172/jci157272}
}
EUVIMED